You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Amgen profit doubles over 2011

TRENTON, N.J. — Biotech drug maker Amgen Inc. said Tuesday that its third-quarter profit more than doubled from a year ago, when a huge legal reserve charge weighed down results. It trounced Wall Street expectations and raised its profit forecast sharply.

The maker of anemia drugs Aranesp and Epogen said net income was $1.11 billion, or $1.41 per share. That’s up from $454 million, or 50 cents a share, in 2011’s third quarter.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week